Collplant生物技术 CLGN 深 沪
等待开盘 01-22 09:30:00 美东时间
1.41
-0.060
-4.08%
华盛通- 最 高1.56
- 今 开1.56
- 成交量 1.59万股
- 最 低 1.40
- 昨 收 1.47
- 总市值 1792.96万
- 52周最高 4.98
- 市盈率 静 --
- 换手率 0.13%
- 52周最低 1.30
- 委 比 98.04%
- 总股本 1271.60万
- 历史最高 24.26
- 量 比 1.27
- 振 幅 10.88%
- 历史最低 1.30
- 每 手 1
- 风险率 0.69%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 美银证券下调哔哩哔哩目标价至31美元；高盛下调诺和诺德目标价至54美元
今日重点评级关注：Benchmark：维持Grupo Televisa"买入"评级，目标价从9美元升至10美元；Truist Securities：维持迪尔股份"买入"评级，目标价从609美元升至612美元
2025-12-01 14:33
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target
D. Boral Capital analyst Jason Kolbert maintains CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and maintains $12 price target.
2025-11-28 22:06
CollPlant Biotechnologies shares are trading lower after the company reported worse-than-expected Q3 financial results.
CollPlant Biotechnologies shares are trading lower after the company reported w...
2025-11-26 22:00
CollPlant Biotechnologies Q3 Adj. EPS $(0.25) Misses $0.15 Estimate, Sales $77.000K Miss $4.845M Estimate
CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $0.15 by 261.29 percent. This is a 24.24 percent increase over losses of $(0.33) per
2025-11-26 20:43
Earnings Scheduled For November 26, 2025
Companies Reporting Before The Bell • Deere (NYSE:DE) is estimated to report qu...
2025-11-26 19:11
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada
-- New North American logistics center will provide expanded distribution for CollPlant's rhCollagen and BioInks as well as enable logistical efficiencies -- REHOVOT, Israel, Oct. 27, 2025 /...
2025-10-27 19:01
美股大行评级 | 潜在涨幅344.44%！Rani Therapeutics获Maxim Group升目标价至10美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持Rani Therapeutics Hldgs"买入"评级，目标价从5美元升至10美元；韦德布什：维持Corbus Pharmaceuticals"跑赢大市"评级，目标价从31美元升至38美元
2025-10-21 18:13
CollPlant’s BioInk Outperforms Matrigel in Technion Study
Collplant Holdings ( ($CLGN) ) has issued an announcement. On October 20, 2025,...
2025-10-21 02:29
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target
D. Boral Capital analyst Jason Kolbert maintains CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and maintains $12 price target.
2025-10-20 21:27
